0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Dolutegravir Intermediates Market Research Report 2024
Published Date: November 2024
|
Report Code: QYRE-Auto-36V18429
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Dolutegravir Intermediates Market Research Report 2024
BUY CHAPTERS

Global Dolutegravir Intermediates Market Research Report 2024

Code: QYRE-Auto-36V18429
Report
November 2024
Pages:108
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Dolutegravir Intermediates Market

Dolutegravir intermediates are important chemical building blocks in the synthesis of Dolutegravir and are mainly used in the development and production of anti-HIV drugs. As an HIV integrase inhibitor, the synthesis of Dolutegravir requires a variety of intermediates, which play a key role in forming the core structure of the drug and improving the stability and biological activity of the drug.
The global Dolutegravir Intermediates market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of %during the forecast period 2024-2030.
North American market for Dolutegravir Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Dolutegravir Intermediates is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global manufacturers of Dolutegravir Intermediates include Ginkgo Bioworks, Zymergen, Codexis, Amyris, Novozymes, Gilead Sciences, Merck, Amgen, Enal Drugs, Abiochem Biotechnology, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for Dolutegravir Intermediates, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Dolutegravir Intermediates.
The Dolutegravir Intermediates market size, estimations, and forecasts are provided in terms of output/shipments (Kilotons) and revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Dolutegravir Intermediates market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Dolutegravir Intermediates manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, production, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Dolutegravir Intermediates Market Report

Report Metric Details
Report Name Dolutegravir Intermediates Market
by Type
by Application
Production by Region
  • North America
  • Europe
  • China
  • Japan
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Ginkgo Bioworks, Zymergen, Codexis, Amyris, Novozymes, Gilead Sciences, Merck, Amgen, Enal Drugs, Abiochem Biotechnology, Sineva Pharmaceutical, Bepharm Science&Technology, Weijia Pharma, Bionna Medicine, Mesochem Technology, SynFarm Pharmaceutical, Abydos Pharma, Dingxintong Pharmaceutical
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by region, by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Detailed analysis of Dolutegravir Intermediates manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 3: Production/output, value of Dolutegravir Intermediates by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
  • Chapter 4: Consumption of Dolutegravir Intermediates in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
  • Chapter 5: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 6: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
  • Chapter 8: Analysis of industrial chain, including the upstream and downstream of the industry.
  • Chapter 9: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
  • Chapter 10: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Dolutegravir Intermediates Market report?

Ans: The main players in the Dolutegravir Intermediates Market are Ginkgo Bioworks, Zymergen, Codexis, Amyris, Novozymes, Gilead Sciences, Merck, Amgen, Enal Drugs, Abiochem Biotechnology, Sineva Pharmaceutical, Bepharm Science&Technology, Weijia Pharma, Bionna Medicine, Mesochem Technology, SynFarm Pharmaceutical, Abydos Pharma, Dingxintong Pharmaceutical

What are the Application segmentation covered in the Dolutegravir Intermediates Market report?

Ans: The Applications covered in the Dolutegravir Intermediates Market report are Original Drug, Generic Drug

What are the Type segmentation covered in the Dolutegravir Intermediates Market report?

Ans: The Types covered in the Dolutegravir Intermediates Market report are Difluorobenzoic Acid Derivatives, Oxetane Derivatives, Others

Recommended Reports

HIV & Antiviral Drugs

Drug Intermediates APIs

Pharma Trends & Therapeutics

1 Dolutegravir Intermediates Market Overview
1.1 Product Definition
1.2 Dolutegravir Intermediates by Type
1.2.1 Global Dolutegravir Intermediates Market Value Growth Rate Analysis by Type: 2023 VS 2030
1.2.2 Difluorobenzoic Acid Derivatives
1.2.3 Oxetane Derivatives
1.2.4 Others
1.3 Dolutegravir Intermediates by Application
1.3.1 Global Dolutegravir Intermediates Market Value Growth Rate Analysis by Application: 2023 VS 2030
1.3.2 Original Drug
1.3.3 Generic Drug
1.4 Global Market Growth Prospects
1.4.1 Global Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
1.4.2 Global Dolutegravir Intermediates Production Capacity Estimates and Forecasts (2019-2030)
1.4.3 Global Dolutegravir Intermediates Production Estimates and Forecasts (2019-2030)
1.4.4 Global Dolutegravir Intermediates Market Average Price Estimates and Forecasts (2019-2030)
1.5 Assumptions and Limitations
2 Market Competition by Manufacturers
2.1 Global Dolutegravir Intermediates Production Market Share by Manufacturers (2019-2024)
2.2 Global Dolutegravir Intermediates Production Value Market Share by Manufacturers (2019-2024)
2.3 Global Key Players of Dolutegravir Intermediates, Industry Ranking, 2022 VS 2023
2.4 Global Dolutegravir Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
2.5 Global Dolutegravir Intermediates Average Price by Manufacturers (2019-2024)
2.6 Global Key Manufacturers of Dolutegravir Intermediates, Manufacturing Base Distribution and Headquarters
2.7 Global Key Manufacturers of Dolutegravir Intermediates, Product Offered and Application
2.8 Global Key Manufacturers of Dolutegravir Intermediates, Date of Enter into This Industry
2.9 Dolutegravir Intermediates Market Competitive Situation and Trends
2.9.1 Dolutegravir Intermediates Market Concentration Rate
2.9.2 Global 5 and 10 Largest Dolutegravir Intermediates Players Market Share by Revenue
2.10 Mergers & Acquisitions, Expansion
3 Dolutegravir Intermediates Production by Region
3.1 Global Dolutegravir Intermediates Production Value Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.2 Global Dolutegravir Intermediates Production Value by Region (2019-2030)
3.2.1 Global Dolutegravir Intermediates Production Value Market Share by Region (2019-2024)
3.2.2 Global Forecasted Production Value of Dolutegravir Intermediates by Region (2025-2030)
3.3 Global Dolutegravir Intermediates Production Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
3.4 Global Dolutegravir Intermediates Production by Region (2019-2030)
3.4.1 Global Dolutegravir Intermediates Production Market Share by Region (2019-2024)
3.4.2 Global Forecasted Production of Dolutegravir Intermediates by Region (2025-2030)
3.5 Global Dolutegravir Intermediates Market Price Analysis by Region (2019-2024)
3.6 Global Dolutegravir Intermediates Production and Value, Year-over-Year Growth
3.6.1 North America Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.2 Europe Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.3 China Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
3.6.4 Japan Dolutegravir Intermediates Production Value Estimates and Forecasts (2019-2030)
4 Dolutegravir Intermediates Consumption by Region
4.1 Global Dolutegravir Intermediates Consumption Estimates and Forecasts by Region: 2019 VS 2023 VS 2030
4.2 Global Dolutegravir Intermediates Consumption by Region (2019-2030)
4.2.1 Global Dolutegravir Intermediates Consumption by Region (2019-2030)
4.2.2 Global Dolutegravir Intermediates Forecasted Consumption by Region (2025-2030)
4.3 North America
4.3.1 North America Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.3.2 North America Dolutegravir Intermediates Consumption by Country (2019-2030)
4.3.3 U.S.
4.3.4 Canada
4.4 Europe
4.4.1 Europe Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.4.2 Europe Dolutegravir Intermediates Consumption by Country (2019-2030)
4.4.3 Germany
4.4.4 France
4.4.5 U.K.
4.4.6 Italy
4.4.7 Russia
4.5 Asia Pacific
4.5.1 Asia Pacific Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.5.2 Asia Pacific Dolutegravir Intermediates Consumption by Region (2019-2030)
4.5.3 China
4.5.4 Japan
4.5.5 South Korea
4.5.6 China Taiwan
4.5.7 Southeast Asia
4.5.8 India
4.6 Latin America, Middle East & Africa
4.6.1 Latin America, Middle East & Africa Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030
4.6.2 Latin America, Middle East & Africa Dolutegravir Intermediates Consumption by Country (2019-2030)
4.6.3 Mexico
4.6.4 Brazil
4.6.5 Turkey
4.6.6 GCC Countries
5 Segment by Type
5.1 Global Dolutegravir Intermediates Production by Type (2019-2030)
5.1.1 Global Dolutegravir Intermediates Production by Type (2019-2024)
5.1.2 Global Dolutegravir Intermediates Production by Type (2025-2030)
5.1.3 Global Dolutegravir Intermediates Production Market Share by Type (2019-2030)
5.2 Global Dolutegravir Intermediates Production Value by Type (2019-2030)
5.2.1 Global Dolutegravir Intermediates Production Value by Type (2019-2024)
5.2.2 Global Dolutegravir Intermediates Production Value by Type (2025-2030)
5.2.3 Global Dolutegravir Intermediates Production Value Market Share by Type (2019-2030)
5.3 Global Dolutegravir Intermediates Price by Type (2019-2030)
6 Segment by Application
6.1 Global Dolutegravir Intermediates Production by Application (2019-2030)
6.1.1 Global Dolutegravir Intermediates Production by Application (2019-2024)
6.1.2 Global Dolutegravir Intermediates Production by Application (2025-2030)
6.1.3 Global Dolutegravir Intermediates Production Market Share by Application (2019-2030)
6.2 Global Dolutegravir Intermediates Production Value by Application (2019-2030)
6.2.1 Global Dolutegravir Intermediates Production Value by Application (2019-2024)
6.2.2 Global Dolutegravir Intermediates Production Value by Application (2025-2030)
6.2.3 Global Dolutegravir Intermediates Production Value Market Share by Application (2019-2030)
6.3 Global Dolutegravir Intermediates Price by Application (2019-2030)
7 Key Companies Profiled
7.1 Ginkgo Bioworks
7.1.1 Ginkgo Bioworks Dolutegravir Intermediates Company Information
7.1.2 Ginkgo Bioworks Dolutegravir Intermediates Product Portfolio
7.1.3 Ginkgo Bioworks Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.1.4 Ginkgo Bioworks Main Business and Markets Served
7.1.5 Ginkgo Bioworks Recent Developments/Updates
7.2 Zymergen
7.2.1 Zymergen Dolutegravir Intermediates Company Information
7.2.2 Zymergen Dolutegravir Intermediates Product Portfolio
7.2.3 Zymergen Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.2.4 Zymergen Main Business and Markets Served
7.2.5 Zymergen Recent Developments/Updates
7.3 Codexis
7.3.1 Codexis Dolutegravir Intermediates Company Information
7.3.2 Codexis Dolutegravir Intermediates Product Portfolio
7.3.3 Codexis Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.3.4 Codexis Main Business and Markets Served
7.3.5 Codexis Recent Developments/Updates
7.4 Amyris
7.4.1 Amyris Dolutegravir Intermediates Company Information
7.4.2 Amyris Dolutegravir Intermediates Product Portfolio
7.4.3 Amyris Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.4.4 Amyris Main Business and Markets Served
7.4.5 Amyris Recent Developments/Updates
7.5 Novozymes
7.5.1 Novozymes Dolutegravir Intermediates Company Information
7.5.2 Novozymes Dolutegravir Intermediates Product Portfolio
7.5.3 Novozymes Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.5.4 Novozymes Main Business and Markets Served
7.5.5 Novozymes Recent Developments/Updates
7.6 Gilead Sciences
7.6.1 Gilead Sciences Dolutegravir Intermediates Company Information
7.6.2 Gilead Sciences Dolutegravir Intermediates Product Portfolio
7.6.3 Gilead Sciences Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.6.4 Gilead Sciences Main Business and Markets Served
7.6.5 Gilead Sciences Recent Developments/Updates
7.7 Merck
7.7.1 Merck Dolutegravir Intermediates Company Information
7.7.2 Merck Dolutegravir Intermediates Product Portfolio
7.7.3 Merck Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.7.4 Merck Main Business and Markets Served
7.7.5 Merck Recent Developments/Updates
7.8 Amgen
7.8.1 Amgen Dolutegravir Intermediates Company Information
7.8.2 Amgen Dolutegravir Intermediates Product Portfolio
7.8.3 Amgen Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.8.4 Amgen Main Business and Markets Served
7.8.5 Amgen Recent Developments/Updates
7.9 Enal Drugs
7.9.1 Enal Drugs Dolutegravir Intermediates Company Information
7.9.2 Enal Drugs Dolutegravir Intermediates Product Portfolio
7.9.3 Enal Drugs Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.9.4 Enal Drugs Main Business and Markets Served
7.9.5 Enal Drugs Recent Developments/Updates
7.10 Abiochem Biotechnology
7.10.1 Abiochem Biotechnology Dolutegravir Intermediates Company Information
7.10.2 Abiochem Biotechnology Dolutegravir Intermediates Product Portfolio
7.10.3 Abiochem Biotechnology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.10.4 Abiochem Biotechnology Main Business and Markets Served
7.10.5 Abiochem Biotechnology Recent Developments/Updates
7.11 Sineva Pharmaceutical
7.11.1 Sineva Pharmaceutical Dolutegravir Intermediates Company Information
7.11.2 Sineva Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.11.3 Sineva Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.11.4 Sineva Pharmaceutical Main Business and Markets Served
7.11.5 Sineva Pharmaceutical Recent Developments/Updates
7.12 Bepharm Science&Technology
7.12.1 Bepharm Science&Technology Dolutegravir Intermediates Company Information
7.12.2 Bepharm Science&Technology Dolutegravir Intermediates Product Portfolio
7.12.3 Bepharm Science&Technology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.12.4 Bepharm Science&Technology Main Business and Markets Served
7.12.5 Bepharm Science&Technology Recent Developments/Updates
7.13 Weijia Pharma
7.13.1 Weijia Pharma Dolutegravir Intermediates Company Information
7.13.2 Weijia Pharma Dolutegravir Intermediates Product Portfolio
7.13.3 Weijia Pharma Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.13.4 Weijia Pharma Main Business and Markets Served
7.13.5 Weijia Pharma Recent Developments/Updates
7.14 Bionna Medicine
7.14.1 Bionna Medicine Dolutegravir Intermediates Company Information
7.14.2 Bionna Medicine Dolutegravir Intermediates Product Portfolio
7.14.3 Bionna Medicine Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.14.4 Bionna Medicine Main Business and Markets Served
7.14.5 Bionna Medicine Recent Developments/Updates
7.15 Mesochem Technology
7.15.1 Mesochem Technology Dolutegravir Intermediates Company Information
7.15.2 Mesochem Technology Dolutegravir Intermediates Product Portfolio
7.15.3 Mesochem Technology Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.15.4 Mesochem Technology Main Business and Markets Served
7.15.5 Mesochem Technology Recent Developments/Updates
7.16 SynFarm Pharmaceutical
7.16.1 SynFarm Pharmaceutical Dolutegravir Intermediates Company Information
7.16.2 SynFarm Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.16.3 SynFarm Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.16.4 SynFarm Pharmaceutical Main Business and Markets Served
7.16.5 SynFarm Pharmaceutical Recent Developments/Updates
7.17 Abydos Pharma
7.17.1 Abydos Pharma Dolutegravir Intermediates Company Information
7.17.2 Abydos Pharma Dolutegravir Intermediates Product Portfolio
7.17.3 Abydos Pharma Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.17.4 Abydos Pharma Main Business and Markets Served
7.17.5 Abydos Pharma Recent Developments/Updates
7.18 Dingxintong Pharmaceutical
7.18.1 Dingxintong Pharmaceutical Dolutegravir Intermediates Company Information
7.18.2 Dingxintong Pharmaceutical Dolutegravir Intermediates Product Portfolio
7.18.3 Dingxintong Pharmaceutical Dolutegravir Intermediates Production, Value, Price and Gross Margin (2019-2024)
7.18.4 Dingxintong Pharmaceutical Main Business and Markets Served
7.18.5 Dingxintong Pharmaceutical Recent Developments/Updates
8 Industry Chain and Sales Channels Analysis
8.1 Dolutegravir Intermediates Industry Chain Analysis
8.2 Dolutegravir Intermediates Key Raw Materials
8.2.1 Key Raw Materials
8.2.2 Raw Materials Key Suppliers
8.3 Dolutegravir Intermediates Production Mode & Process
8.4 Dolutegravir Intermediates Sales and Marketing
8.4.1 Dolutegravir Intermediates Sales Channels
8.4.2 Dolutegravir Intermediates Distributors
8.5 Dolutegravir Intermediates Customers
9 Dolutegravir Intermediates Market Dynamics
9.1 Dolutegravir Intermediates Industry Trends
9.2 Dolutegravir Intermediates Market Drivers
9.3 Dolutegravir Intermediates Market Challenges
9.4 Dolutegravir Intermediates Market Restraints
10 Research Findings and Conclusion
11 Methodology and Data Source
11.1 Methodology/Research Approach
11.1.1 Research Programs/Design
11.1.2 Market Size Estimation
11.1.3 Market Breakdown and Data Triangulation
11.2 Data Source
11.2.1 Secondary Sources
11.2.2 Primary Sources
11.3 Author List
11.4 Disclaimer
List of Tables
 Table 1. Global Dolutegravir Intermediates Market Value by Type, (US$ Million) & (2023 VS 2030)
 Table 2. Global Dolutegravir Intermediates Market Value by Application, (US$ Million) & (2023 VS 2030)
 Table 3. Global Dolutegravir Intermediates Production Capacity (Kilotons) by Manufacturers in 2023
 Table 4. Global Dolutegravir Intermediates Production by Manufacturers (2019-2024) & (Kilotons)
 Table 5. Global Dolutegravir Intermediates Production Market Share by Manufacturers (2019-2024)
 Table 6. Global Dolutegravir Intermediates Production Value by Manufacturers (2019-2024) & (US$ Million)
 Table 7. Global Dolutegravir Intermediates Production Value Share by Manufacturers (2019-2024)
 Table 8. Global Key Players of Dolutegravir Intermediates, Industry Ranking, 2022 VS 2023
 Table 9. Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Production Value in Dolutegravir Intermediates as of 2023)
 Table 10. Global Market Dolutegravir Intermediates Average Price by Manufacturers (US$/Ton) & (2019-2024)
 Table 11. Global Key Manufacturers of Dolutegravir Intermediates, Manufacturing Base Distribution and Headquarters
 Table 12. Global Key Manufacturers of Dolutegravir Intermediates, Product Offered and Application
 Table 13. Global Key Manufacturers of Dolutegravir Intermediates, Date of Enter into This Industry
 Table 14. Global Dolutegravir Intermediates Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 15. Mergers & Acquisitions, Expansion Plans
 Table 16. Global Dolutegravir Intermediates Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Table 17. Global Dolutegravir Intermediates Production Value (US$ Million) by Region (2019-2024)
 Table 18. Global Dolutegravir Intermediates Production Value Market Share by Region (2019-2024)
 Table 19. Global Dolutegravir Intermediates Production Value (US$ Million) Forecast by Region (2025-2030)
 Table 20. Global Dolutegravir Intermediates Production Value Market Share Forecast by Region (2025-2030)
 Table 21. Global Dolutegravir Intermediates Production Comparison by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Table 22. Global Dolutegravir Intermediates Production (Kilotons) by Region (2019-2024)
 Table 23. Global Dolutegravir Intermediates Production Market Share by Region (2019-2024)
 Table 24. Global Dolutegravir Intermediates Production (Kilotons) Forecast by Region (2025-2030)
 Table 25. Global Dolutegravir Intermediates Production Market Share Forecast by Region (2025-2030)
 Table 26. Global Dolutegravir Intermediates Market Average Price (US$/Ton) by Region (2019-2024)
 Table 27. Global Dolutegravir Intermediates Market Average Price (US$/Ton) by Region (2025-2030)
 Table 28. Global Dolutegravir Intermediates Consumption Growth Rate by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Table 29. Global Dolutegravir Intermediates Consumption by Region (2019-2024) & (Kilotons)
 Table 30. Global Dolutegravir Intermediates Consumption Market Share by Region (2019-2024)
 Table 31. Global Dolutegravir Intermediates Forecasted Consumption by Region (2025-2030) & (Kilotons)
 Table 32. Global Dolutegravir Intermediates Forecasted Consumption Market Share by Region (2019-2024)
 Table 33. North America Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kilotons)
 Table 34. North America Dolutegravir Intermediates Consumption by Country (2019-2024) & (Kilotons)
 Table 35. North America Dolutegravir Intermediates Consumption by Country (2025-2030) & (Kilotons)
 Table 36. Europe Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kilotons)
 Table 37. Europe Dolutegravir Intermediates Consumption by Country (2019-2024) & (Kilotons)
 Table 38. Europe Dolutegravir Intermediates Consumption by Country (2025-2030) & (Kilotons)
 Table 39. Asia Pacific Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kilotons)
 Table 40. Asia Pacific Dolutegravir Intermediates Consumption by Region (2019-2024) & (Kilotons)
 Table 41. Asia Pacific Dolutegravir Intermediates Consumption by Region (2025-2030) & (Kilotons)
 Table 42. Latin America, Middle East & Africa Dolutegravir Intermediates Consumption Growth Rate by Country: 2019 VS 2023 VS 2030 (Kilotons)
 Table 43. Latin America, Middle East & Africa Dolutegravir Intermediates Consumption by Country (2019-2024) & (Kilotons)
 Table 44. Latin America, Middle East & Africa Dolutegravir Intermediates Consumption by Country (2025-2030) & (Kilotons)
 Table 45. Global Dolutegravir Intermediates Production (Kilotons) by Type (2019-2024)
 Table 46. Global Dolutegravir Intermediates Production (Kilotons) by Type (2025-2030)
 Table 47. Global Dolutegravir Intermediates Production Market Share by Type (2019-2024)
 Table 48. Global Dolutegravir Intermediates Production Market Share by Type (2025-2030)
 Table 49. Global Dolutegravir Intermediates Production Value (US$ Million) by Type (2019-2024)
 Table 50. Global Dolutegravir Intermediates Production Value (US$ Million) by Type (2025-2030)
 Table 51. Global Dolutegravir Intermediates Production Value Market Share by Type (2019-2024)
 Table 52. Global Dolutegravir Intermediates Production Value Market Share by Type (2025-2030)
 Table 53. Global Dolutegravir Intermediates Price (US$/Ton) by Type (2019-2024)
 Table 54. Global Dolutegravir Intermediates Price (US$/Ton) by Type (2025-2030)
 Table 55. Global Dolutegravir Intermediates Production (Kilotons) by Application (2019-2024)
 Table 56. Global Dolutegravir Intermediates Production (Kilotons) by Application (2025-2030)
 Table 57. Global Dolutegravir Intermediates Production Market Share by Application (2019-2024)
 Table 58. Global Dolutegravir Intermediates Production Market Share by Application (2025-2030)
 Table 59. Global Dolutegravir Intermediates Production Value (US$ Million) by Application (2019-2024)
 Table 60. Global Dolutegravir Intermediates Production Value (US$ Million) by Application (2025-2030)
 Table 61. Global Dolutegravir Intermediates Production Value Market Share by Application (2019-2024)
 Table 62. Global Dolutegravir Intermediates Production Value Market Share by Application (2025-2030)
 Table 63. Global Dolutegravir Intermediates Price (US$/Ton) by Application (2019-2024)
 Table 64. Global Dolutegravir Intermediates Price (US$/Ton) by Application (2025-2030)
 Table 65. Ginkgo Bioworks Dolutegravir Intermediates Company Information
 Table 66. Ginkgo Bioworks Dolutegravir Intermediates Specification and Application
 Table 67. Ginkgo Bioworks Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 68. Ginkgo Bioworks Main Business and Markets Served
 Table 69. Ginkgo Bioworks Recent Developments/Updates
 Table 70. Zymergen Dolutegravir Intermediates Company Information
 Table 71. Zymergen Dolutegravir Intermediates Specification and Application
 Table 72. Zymergen Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 73. Zymergen Main Business and Markets Served
 Table 74. Zymergen Recent Developments/Updates
 Table 75. Codexis Dolutegravir Intermediates Company Information
 Table 76. Codexis Dolutegravir Intermediates Specification and Application
 Table 77. Codexis Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 78. Codexis Main Business and Markets Served
 Table 79. Codexis Recent Developments/Updates
 Table 80. Amyris Dolutegravir Intermediates Company Information
 Table 81. Amyris Dolutegravir Intermediates Specification and Application
 Table 82. Amyris Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 83. Amyris Main Business and Markets Served
 Table 84. Amyris Recent Developments/Updates
 Table 85. Novozymes Dolutegravir Intermediates Company Information
 Table 86. Novozymes Dolutegravir Intermediates Specification and Application
 Table 87. Novozymes Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 88. Novozymes Main Business and Markets Served
 Table 89. Novozymes Recent Developments/Updates
 Table 90. Gilead Sciences Dolutegravir Intermediates Company Information
 Table 91. Gilead Sciences Dolutegravir Intermediates Specification and Application
 Table 92. Gilead Sciences Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 93. Gilead Sciences Main Business and Markets Served
 Table 94. Gilead Sciences Recent Developments/Updates
 Table 95. Merck Dolutegravir Intermediates Company Information
 Table 96. Merck Dolutegravir Intermediates Specification and Application
 Table 97. Merck Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 98. Merck Main Business and Markets Served
 Table 99. Merck Recent Developments/Updates
 Table 100. Amgen Dolutegravir Intermediates Company Information
 Table 101. Amgen Dolutegravir Intermediates Specification and Application
 Table 102. Amgen Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 103. Amgen Main Business and Markets Served
 Table 104. Amgen Recent Developments/Updates
 Table 105. Enal Drugs Dolutegravir Intermediates Company Information
 Table 106. Enal Drugs Dolutegravir Intermediates Specification and Application
 Table 107. Enal Drugs Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 108. Enal Drugs Main Business and Markets Served
 Table 109. Enal Drugs Recent Developments/Updates
 Table 110. Abiochem Biotechnology Dolutegravir Intermediates Company Information
 Table 111. Abiochem Biotechnology Dolutegravir Intermediates Specification and Application
 Table 112. Abiochem Biotechnology Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 113. Abiochem Biotechnology Main Business and Markets Served
 Table 114. Abiochem Biotechnology Recent Developments/Updates
 Table 115. Sineva Pharmaceutical Dolutegravir Intermediates Company Information
 Table 116. Sineva Pharmaceutical Dolutegravir Intermediates Specification and Application
 Table 117. Sineva Pharmaceutical Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 118. Sineva Pharmaceutical Main Business and Markets Served
 Table 119. Sineva Pharmaceutical Recent Developments/Updates
 Table 120. Bepharm Science&Technology Dolutegravir Intermediates Company Information
 Table 121. Bepharm Science&Technology Dolutegravir Intermediates Specification and Application
 Table 122. Bepharm Science&Technology Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 123. Bepharm Science&Technology Main Business and Markets Served
 Table 124. Bepharm Science&Technology Recent Developments/Updates
 Table 125. Weijia Pharma Dolutegravir Intermediates Company Information
 Table 126. Weijia Pharma Dolutegravir Intermediates Specification and Application
 Table 127. Weijia Pharma Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 128. Weijia Pharma Main Business and Markets Served
 Table 129. Weijia Pharma Recent Developments/Updates
 Table 130. Bionna Medicine Dolutegravir Intermediates Company Information
 Table 131. Bionna Medicine Dolutegravir Intermediates Specification and Application
 Table 132. Bionna Medicine Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 133. Bionna Medicine Main Business and Markets Served
 Table 134. Bionna Medicine Recent Developments/Updates
 Table 135. Mesochem Technology Dolutegravir Intermediates Company Information
 Table 136. Mesochem Technology Dolutegravir Intermediates Specification and Application
 Table 137. Mesochem Technology Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 138. Mesochem Technology Main Business and Markets Served
 Table 139. Mesochem Technology Recent Developments/Updates
 Table 140. SynFarm Pharmaceutical Dolutegravir Intermediates Company Information
 Table 141. SynFarm Pharmaceutical Dolutegravir Intermediates Specification and Application
 Table 142. SynFarm Pharmaceutical Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 143. SynFarm Pharmaceutical Main Business and Markets Served
 Table 144. SynFarm Pharmaceutical Recent Developments/Updates
 Table 145. Abydos Pharma Dolutegravir Intermediates Company Information
 Table 146. Abydos Pharma Dolutegravir Intermediates Specification and Application
 Table 147. Abydos Pharma Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 148. Abydos Pharma Main Business and Markets Served
 Table 149. Abydos Pharma Recent Developments/Updates
 Table 150. Dingxintong Pharmaceutical Dolutegravir Intermediates Company Information
 Table 151. Dingxintong Pharmaceutical Dolutegravir Intermediates Specification and Application
 Table 152. Dingxintong Pharmaceutical Dolutegravir Intermediates Production (Kilotons), Value (US$ Million), Price (US$/Ton) and Gross Margin (2019-2024)
 Table 153. Dingxintong Pharmaceutical Main Business and Markets Served
 Table 154. Dingxintong Pharmaceutical Recent Developments/Updates
 Table 155. Key Raw Materials Lists
 Table 156. Raw Materials Key Suppliers Lists
 Table 157. Dolutegravir Intermediates Distributors List
 Table 158. Dolutegravir Intermediates Customers List
 Table 159. Dolutegravir Intermediates Market Trends
 Table 160. Dolutegravir Intermediates Market Drivers
 Table 161. Dolutegravir Intermediates Market Challenges
 Table 162. Dolutegravir Intermediates Market Restraints
 Table 163. Research Programs/Design for This Report
 Table 164. Key Data Information from Secondary Sources
 Table 165. Key Data Information from Primary Sources
 Table 166. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Dolutegravir Intermediates
 Figure 2. Global Dolutegravir Intermediates Market Value by Type, (US$ Million) & (2023 VS 2030)
 Figure 3. Global Dolutegravir Intermediates Market Share by Type: 2023 VS 2030
 Figure 4. Difluorobenzoic Acid Derivatives Product Picture
 Figure 5. Oxetane Derivatives Product Picture
 Figure 6. Others Product Picture
 Figure 7. Global Dolutegravir Intermediates Market Value by Application, (US$ Million) & (2023 VS 2030)
 Figure 8. Global Dolutegravir Intermediates Market Share by Application: 2023 VS 2030
 Figure 9. Original Drug
 Figure 10. Generic Drug
 Figure 11. Global Dolutegravir Intermediates Production Value (US$ Million), 2019 VS 2023 VS 2030
 Figure 12. Global Dolutegravir Intermediates Production Value (US$ Million) & (2019-2030)
 Figure 13. Global Dolutegravir Intermediates Production Capacity (Kilotons) & (2019-2030)
 Figure 14. Global Dolutegravir Intermediates Production (Kilotons) & (2019-2030)
 Figure 15. Global Dolutegravir Intermediates Average Price (US$/Ton) & (2019-2030)
 Figure 16. Dolutegravir Intermediates Report Years Considered
 Figure 17. Dolutegravir Intermediates Production Share by Manufacturers in 2023
 Figure 18. Dolutegravir Intermediates Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2019 VS 2023
 Figure 19. The Global 5 and 10 Largest Players: Market Share by Dolutegravir Intermediates Revenue in 2023
 Figure 20. Global Dolutegravir Intermediates Production Value by Region: 2019 VS 2023 VS 2030 (US$ Million)
 Figure 21. Global Dolutegravir Intermediates Production Value Market Share by Region: 2019 VS 2023 VS 2030
 Figure 22. Global Dolutegravir Intermediates Production Comparison by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Figure 23. Global Dolutegravir Intermediates Production Market Share by Region: 2019 VS 2023 VS 2030
 Figure 24. North America Dolutegravir Intermediates Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 25. Europe Dolutegravir Intermediates Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 26. China Dolutegravir Intermediates Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 27. Japan Dolutegravir Intermediates Production Value (US$ Million) Growth Rate (2019-2030)
 Figure 28. Global Dolutegravir Intermediates Consumption by Region: 2019 VS 2023 VS 2030 (Kilotons)
 Figure 29. Global Dolutegravir Intermediates Consumption Market Share by Region: 2019 VS 2023 VS 2030
 Figure 30. North America Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 31. North America Dolutegravir Intermediates Consumption Market Share by Country (2019-2030)
 Figure 32. U.S. Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 33. Canada Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 34. Europe Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 35. Europe Dolutegravir Intermediates Consumption Market Share by Country (2019-2030)
 Figure 36. Germany Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 37. France Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 38. U.K. Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 39. Italy Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 40. Russia Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 41. Asia Pacific Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 42. Asia Pacific Dolutegravir Intermediates Consumption Market Share by Region (2025-2030)
 Figure 43. China Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 44. Japan Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 45. South Korea Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 46. China Taiwan Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 47. Southeast Asia Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 48. India Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 49. Latin America, Middle East & Africa Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 50. Latin America, Middle East & Africa Dolutegravir Intermediates Consumption Market Share by Country (2019-2030)
 Figure 51. Mexico Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 52. Brazil Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 53. Turkey Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 54. GCC Countries Dolutegravir Intermediates Consumption and Growth Rate (2019-2030) & (Kilotons)
 Figure 55. Global Production Market Share of Dolutegravir Intermediates by Type (2019-2030)
 Figure 56. Global Production Value Market Share of Dolutegravir Intermediates by Type (2019-2030)
 Figure 57. Global Dolutegravir Intermediates Price (US$/Ton) by Type (2019-2030)
 Figure 58. Global Production Market Share of Dolutegravir Intermediates by Application (2019-2030)
 Figure 59. Global Production Value Market Share of Dolutegravir Intermediates by Application (2019-2030)
 Figure 60. Global Dolutegravir Intermediates Price (US$/Ton) by Application (2019-2030)
 Figure 61. Dolutegravir Intermediates Value Chain
 Figure 62. Dolutegravir Intermediates Production Process
 Figure 63. Channels of Distribution (Direct Vs Distribution)
 Figure 64. Bottom-up and Top-down Approaches for This Report
 Figure 65. Data Triangulation
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Accenture